(BFW) *STATOIL SAYS TOO EARLY TO SAY IF TO BE ROSNEFT DRILLING NEXT YR


BN 08/25 07:21 *STATOIL CEO HELGE LUND COMMENTED IN INTERVIEW IN STAVANGER
BN 08/25 07:21 *STATOIL SAYS TOO EARLY TO SAY IF TO BE ROSNEFT DRILLING NEXT YR
BN 08/25 07:21 *STATOIL ALLIGNING ROSNEFT AGREEMENT TO ENSURE COMPLY W/SANCTION
BN 08/25 07:21 *STATOIL CEO WON'T SAY WHICH PROJECTS W/ROSNEFT WILL BE AFFECTED
BN 08/25 07:21 *STATOIL SAYS ROSNEFT CO-OPERATION CHALLENGING AFTER SANCTIONS

*STATOIL SAYS TOO EARLY TO SAY IF TO BE ROSNEFT DRILLING NEXT YR
2014-08-25 07:24:09.282 GMT

--BENJAMIN DOW

-0- Aug/25/2014 07:24 GMT

>>> eircom opts for sale rather than IPO

eircom opts for sale rather than IPO 

eircom, the Irish telecoms group, is believed to have abandoned any plans for a flotation, the Irish Independent reported, citing a weekend report.

The company has decided instead to try and find a buyer, the report said, noting that its advisers have been recommending a sale to a private-equity house or trade buyer.

The move is thought to be backed by eircom’s owners, which include the private-equity firm Blackstone, the item said.

A flotation had been expected to value eircom at approximately EUR 3bn, the report said, adding that the potential float proceeds had been earmarked for paying down debt.


Source Irish Independent

>>> What to look at today - 25/08/2014 (UK Close)

After closing slightly down on friday, S&P is trading higher this morning Futures are +0.43% higher...
USD was firmly bid in the opening hours of the Asia session, rising about 0.3% against EUR (50 pips below 1.3190) and JPY (40 pips above 102.20) to hit respective 7- and 11-month highs. FX market action implying a greater conviction that Yellen was less dogmatically dovish - giving credence to a more even handed debate about risks of normalizing policy too early AND too late. Reports also suggesting Yellen may be more willing to accept the possibility of structural changes producing labor slack, which would deem extended use of easy monetary policy less effective. In contrast, there is no debate that Friday comments from ECB's Draghi and BOJ's Kuroda were substantially more dovish. Draghi was increasingly vocal to prefer more policy adjustment to austerity and fiscal consolidation. Kuroda noted inflation is still just halfway to meeting its target, and that he will not hesitate to adjust policy "if we fall short of the inflation goal."...As european mkts stay volatile on Ukraine situation, Minsk summit will be closely monitored...M&A announcement (ITMN/ROG...THI/BKW...) also helpening semtiment this morning...Nikkei +0.54% Hang Seng +0.21% Shanghai -0.22%


Eur$ 1.3206 S&P +0.43% SX5E +0.97% FTSE Closed DAX +0.86% SMI +0.54%

Keep an eye on :
- ACS SM : ACS Seeks to Sell Renewable Energy Assets, Confidencial Reports
- AIR FP : Airbus considers sale of Atlas Elektronik stake; could prompt new bid from Thales
- AIR FP : Galileo Satellites Missed Targeted Orbit, Arianespace Says
- BBY LN : Balfour May Boost Its Infrastructure Investments: Sunday Times
- BG/ LN : said to be in talks to sell stake in Tanzanian Gas Field (BG hold 60% stake in Block 3)
- BELG BB : Bpost/Belgacom stake sale not a priority for Belgian government
- BKIA SM : Spain Won’t Sell More Bankia Shares Before October, EP Reports
- BPOST BB : Bpost/Belgacom stake sale not a priority for Belgian government
- CON GY : Continental to Extend French Distribution Network, Figaro Says
- DL NA : Delta Lloyd Considers Offer for Insurer Vivat: Telegraaf Link
- IM NA : Imtech Hires Goldman Sachs for Negotiations on Debt: FD Link
- NESN VX : Nestle Buyback Starts Today, Runs Through Dec. 30, 2015
- NOK1V FH : The Finnish network equipment maker Nokia’s Here mapping service could be in the radar for the Chinese GeoStar, according to Kauppalehti.
- POG LN : Said to be in talks with a China state bank regarding possible bailout
- ROG VX : Roche Agrees to Buy Intermune in $8.3b Transaction, 38% premium vs Fr. close
- ROG VX : Chugai Falls Most in 3 Yrs; Roche Said to Decide to Drop Buyout
- RTL BB : RTL Group Should Pay its Taxes, Hungarian Government Says: WSJ
- SIE GY : Siemens Aims to Make Offshore Wind Farms Cheaper: Handelsblatt
- TEF SM : Telefonica Considers Raising Bid for Vivendi’s GVT: Messaggero {NSN NAR3AZ6TTDS0 <go>}
- TFI FP : TF1 Signs Star Wars Accord With Walt Disney France: Le Figaro
- UCB BB : Actavis Confirms Patent Challenge for Generic of UCB’s Neupro
- VIV FP : Vivendi Well-Placed With Offers From GVT Suitors, Investir Says {NSN NARC8H6TTDS0 <go>}
- VVT LN : Delta Lloyd Considers Offer for Insurer Vivat: Telegraaf Link
- WPP LN : WPP’s Russia Profit to Fall Over Ukraine, Sorrell Tells Express
- WRT1V FH : Possibility Rolls Royce may consider another Wartsila offer remains - Arvopaperi

>>> Brokers Upgrades & Downgrades

>>> Up
*ARKEMA RAISED TO BUY AT DEUTSCHE BANK
*EURAZEO RAISED TO BUY VS HOLD AT SOCGEN
*SYNTHOMER RAISED TO BUY AT DEUTSCHE BANK
*UNIBAIL-RODAMCO RAISED TO BUY VS HOLD AT SOCGEN

>>> Down
*BAUER CUT TO HOLD VS BUY AT BANKHAUS LAMPE
*UMICORE CUT TO SELL AT DEUTSCHE BANK

>>> PT changes


>>> Initiation


>>> Call

FT : Pfizer weighs options on AstraZeneca bid

Pfizer is considering its acquisition options as a potential path opens this week for the US drugmaker to renew its pursuit of AstraZeneca.
Tuesday marks three months since the collapse of Pfizer’s £69.4bn takeover approach for Britain’s second-biggest

From that point onwards AstraZeneca would be allowed under UK Takeover Panel rules to invite Pfizer back to the negotiating table, or the US company would be permitted to make one fresh take-it-or-leave-it offer in private.
Pfizer is barred under those rules from talking publicly about any renewed interest in AstraZeneca but Ian Read, chief executive, has said he is continuing to look “aggressively” at potential acquisitions.
Speculation about a possible new bid has lifted AstraZeneca’s shares by 7.5 per cent in the past week to £44.18 but they remain well below the £55 per share cash and stock Pfizer offer that was rejected in May.
Analysts and bankers rate the chances of an immediate resumption of talks as low because AstraZeneca appears as committed as ever to its go-it-alone strategy – talking up the prospects of its drug pipeline and highlighting the risks of a disruptive merger.
Several big AstraZeneca shareholders made clear in May that they would have favoured more talks with Pfizer but there has been no sign of a concerted campaign to force the board back to the table.
Aside from the private one-shot offer allowed after Tuesday, Pfizer cannot take any further steps without an invitation from AstraZeneca to engage.
Only in November, when the full six-month cooling-off period expires, would Pfizer be allowed to make a fresh approach in public.
Analysts say AstraZeneca remains an attractive target for Pfizer, which is looking for acquisitions to replenish its pipeline and to absorb some of the tens of billions of dollars of cash it has trapped offshore.
However, any new bid would face political risks on both sides of the Atlantic.
A Pfizer takeover of AstraZeneca would be by far the biggest of the so-called “tax inversions” by US companies that are facing increasing opposition in Washington.
By acquiring AstraZeneca and shifting its official home to the UK, Pfizer would shelter its overseas revenues from the 35 per cent US corporate tax rate.
US President Barack Obama has branded companies attempting such deals as “corporate deserters” and threatened executive action to stop them, while Democrats on Capitol Hill are working on legislation to halt the practice.
The decision this month by Walgreens, the US pharmacy chain, to pass up an opportunity to move its tax home to Switzerland as part of a deal with Alliance Boots has been seen as a sign that political pressure is starting to deter inversions.
Some bankers and analysts believe Walgreens was especially sensitive to the controversy because it is a consumer-facing business and say that Pfizer is less likely to be discouraged by rhetoric alone.
These people predict that Pfizer would prefer to delay any fresh inversion attempt until after the US midterm elections in November to avoid making itself a campaign issue. However, the longer Pfizer delays, the greater the political risks would be in the UK as parties gear up for next May’s general election.
Pfizer’s initial approach last spring sparked calls from the opposition Labour party for any deal to be subjected to a public interest test, with the prospect of government intervention if it were found to threaten the UK science base. This debate would be amplified further in the run-up to polling.
Valuation could also remain an obstacle given the impasse last May between Pfizer’s £55-per-share final offer and AstraZeneca’s demand for at least £58.50 before it would consider a deal.

WSJ : Burger King in Talks to Buy Tim Hortons in Canada Tax Deal

Burger King in Talks to Buy Tim Hortons in Canada Tax Deal
Tie-Up Would Be Structured as Tax Inversion With a Combined Market Value of About $18 Billion

Burger King Worldwide Inc. BKW +1.01% is in talks to buy Canadian coffee-and-doughnut chain Tim Hortons Inc., THI.T +2.79% a deal that would be structured as a so-called tax inversion and move the hamburger seller's base to Canada.

The two sides are working on a deal that would create a new company, they said in a statement, confirming a report on the talks by The Wall Street Journal. The takeover would create the third-largest quick-service restaurant provider in the world, they said.

Inversion deals have been on the rise lately, and are facing stiff opposition in Washington given that they threaten to deplete U.S. government coffers. A move by Burger King to seal one is sure to intensify criticism of them, since it is such a well-known and distinctly American brand.

A person familiar with the matter said a deal between the two companies could be struck soon, though additional details on timing couldn't be learned. Tim Hortons has a market value of about $8.4 billion, while Burger King's is about $9.6 billion, so together the restaurant companies are currently worth about $18 billion.

By moving to a lower-tax jurisdiction, inversion deals enable companies to save money on foreign earnings and cash stowed abroad, and in some cases lower their overall corporate rate. Even though many of the headline-grabbing inversion deals of late have involved European companies, Canada has also been the focal point for a number of them, given its proximity and similarity to the U.S. Canada's federal corporate tax rate was lowered to 15% in 2012.

Valeant Pharmaceuticals International Inc., VRX.T +3.06% which had been based in California, combined with Canada's Biovail Corp. in 2010 and redomiciled in Canada. The company now has a tax rate less than 5%.

After a tide of tax-inversion deals—including AbbVie Inc. ABBV +0.44% 's agreed purchase of Ireland's Shire SHPG +0.04% PLC and Medtronic Inc. MDT -0.80% 's agreement to buy Ireland's Covidien COV -0.85% PLC, with other deals expected in the coming months—the White House called on Congress to take steps to prevent companies from pursuing inversions. The Treasury Department recently said it is assembling a list of options to deter or prevent the deals for Secretary Jacob Lew to consider.

Nevertheless, Burger King, whose initial approach to Tim Hortons came more than a month ago, doesn't plan to have a provision in a merger agreement that would allow it to walk away from a deal if laws are passed that diminish the benefits of inverting, people familiar with the matter said.

In the current wave of such deals, most inversions have been struck by health-care companies. An inversion deal by Burger King would suggest that the deals have wider appeal beyond the health industry, as companies from a range of industries consider ways to become more competitive from a tax perspective.

Burger King was founded in 1954 with a single restaurant in Miami, where it is now based. It has since grown to be the world's second-largest hamburger chain, according to the company's website. There are more than 13,000 Burger King locations in nearly 100 countries, serving more than 11 million people daily, the site says.

Tim Hortons, based in Oakville, Ontario, is well-known for its coffee, a high-margin business line in which U.S. fast-food giants have raced to grab market share. Burger King has been adding more coffee items and flavors to its menus to catch up with rival McDonald's Corp. MCD -0.08% , which has had success with a specialty coffee line called McCafe. Burger King paired up with Seattle's Best Coffee, a brand owned by Starbuck's Corp., to help its effort gain traction.

In 1995, Wendy's Co. WEN +1.04% acquired Tim Hortons. At the time, the fast-food company's executives were looking for growth outside of the burger market.

Activist hedge fund Pershing Square Capital Management, run by William Ackman, and Trian Fund Management later accumulated stakes in Wendy's and demanded that the company spin off the Canadian chain, which it did in 2006.

Last year, hedge funds Scout Capital Management LLC and Highfields Capital Management LP announced stakes in Tim Hortons and called for the company to curtail its U.S. expansion plans and increase its leverage to buy back more shares.

In 2010, Brazilian private-equity firm 3G Capital Management bought Burger King and took the chain known for its Whopper burgers private. A few years later, the company structured a complex deal with an investment vehicle co-owned by Mr. Ackman to go public again, while retaining control of the company.

3G, which has offices in Rio de Janeiro and New York, has become a major player in the U.S. food sector, with a taste for iconic brands. Billionaire co-founder Jorge Paulo Lemann was a big shareholder in brewer InBev and helped engineer its 2008 acquisition of Anheuser-Busch. 3G last year teamed up with Warren Buffett to buy U.S. ketchup maker H.J. Heinz Co. for $23 billion, one of the largest deals of the year.

A key rationale for the deal is the potential to leverage Burger King's expertise in global development to boost Tim Hortons' international growth, the companies said, adding they plan operate the two as stand-alone brands.

>>> Asian Update

Asian Market Update: USD gains as investors conclude Yellen shifted into "Neutral"

***Economic Data*** - (HU) Hungary Aug GKI Business Confidence: 2.2 v 1.4 prior, Consumer Confidence: -21.9 (9-month low) v -18.9 prior

***Index Snapshot (as of 02:30 GMT)*** - Nikkei225 +0.2%, S&P/ASX -0.3%, Kospi +0.1%, Shanghai Composite -0.8%, Hang Seng -0.6%, Sept S&P500 +0.1% at 1,990

***Commodities/Fixed Income/Currencies*** - Dec gold -0.1% at $1,279, Oct crude oil -0.2% at $93.50/brl, Sept Copper flat at $3.20/lb - (KR) South Korea sells 20-yr bond at average yield of 3.305% - (JP) BOJ offers to buy ¥450B in CP - USD/CNY: (CN) PBoC sets yuan mid point at 6.1653 v 6.1617 prior setting (weakest setting since Aug 6th)

***Market Focal Points/Key Themes*** - USD was firmly bid in the opening hours of the Asia session, rising about 0.3% against EUR (50 pips below 1.3190) and JPY (40 pips above 102.20) to hit respective 7- and 11-month highs. FX market action implying a greater conviction that Yellen was less dogmatically dovish - giving credence to a more even handed debate about risks of normalizing policy too early AND too late. Reports also suggesting Yellen may be more willing to accept the possibility of structural changes producing labor slack, which would deem extended use of easy monetary policy less effective. In contrast, there is no debate that Friday comments from ECB's Draghi and BOJ's Kuroda were substantially more dovish. Draghi was increasingly vocal to prefer more policy adjustment to austerity and fiscal consolidation. Kuroda noted inflation is still just halfway to meeting its target, and that he will not hesitate to adjust policy "if we fall short of the inflation goal."

- Merger-mania Monday is abuzz with two large deals announced over the weekend. InterMune agreed to be acquired by Roche at $74/shr in a $8.3B deal, which is also weighing heavily on Japan's Chugai Pharmaceutical after recent speculation that it would be Roche's acquisition target. Fast-food giant Burger King confirmed press reports it was in preliminary talks to merge with Tim Horton that would result in the world's third-largest quick service restaurant company. BK did note the transaction remains subject to negotiation of definitive agreements.

- Ahead of Monday's Minsk summit, German Chancellor Merkel struck a measured tone, calling for a solution that does not harm Russia and allows Ukraine to pick its own fate. Merkel said she is welcoming the summit, but warned they probably will not bring any "decisive breakthrough". Recall earlier on Friday, Russian humanitarian convoy refused to wait for Ukraine approval, rolling through the border without full inspection by the Red Cross and prompting accusations of an invasion from Kiev's Defense Ministry officials.

***Equities*** US markets: - THI: Burger King in talks to acquire Tim Hortons; Deal could be reached soon - financial press - ITMN: To be acquired by Roche at $74.00/shr in an all-cash deal valued at approx $8.3B on fully diluted basis - QIHU: Reports Q2 $0.50 v $0.43e, Rev $317.9M v $295Me - AMZN: Said to be developing its own advertising software aimed at competing with Google adwords - financial press - GS: Announces settlement agreements with FHFA over RMBS sales; Goldman to repurchase $3.15B in RMBS sold to Fannie and Freddie

Notable movers by sector: - Materials: Bluescope Steel BSL.AU -12.5% (FY14 results); Western Areas WSA.AU +1.9% (FY14 results); Orora Ltd ORA.AU +9.9% (FY14 results) - Energy: Beach Energy BPT.AU 0.7% (FY14 results); Goldwind 2208.HK +18.3% (H1 results); Sinopec 386.HK +1.7% (H1 results) - Industrials: Leighton Holdings LEI.AU -0.2% (to sell marine unit); BYD 1211.HK -3.4% (H1 results); Great Wall Motor 2333.HK +3.6% (final H1 results) - Healthcare: Chugai Pharmaceutical 4519.JP -8.9% (Roche CEO declines to comment on acquisition speculation); Sinopharm 1099.HK +2.3% (H1 results)

Inversion-Deal Express Slows as Obama Condemns CEOs: Real M&A

+------------------------------------------------------------------------------+

Inversion-Deal Express Slows as Obama Condemns CEOs: Real M&A 2014-08-24 23:00:00.8 GMT

(For a Real M&A column news alert: SALT REALMNA <GO>.)

By Matthew Campbell, Manuel Baigorri and David Welch Aug. 25 (Bloomberg) -- President Barack Obama’s full- throated denunciation of overseas mergers that lower U.S. companies’ taxes is throwing cold water on potential deals. On July 24 Obama referred to companies looking to shift their domicile as “corporate deserters” and aides pledged to curtail the practice with or without Congressional approval. Since then, no companies have announced any of these deals -- known as inversions -- and it’s no coincidence, according to lawyers and investment bankers. The presidential rhetoric has caused several companies exploring inversions to put on the brakes to see what emerges from the political debate, people familiar with the preparations said. The new caution was seen earlier this month when Walgreen Co., the largest U.S. drugstore, passed on the opportunity to move its domicile to low-tax Switzerland when it bought Alliance Boots GmbH. Pfizer Inc., which is on the hunt for inversion targets in Europe after a failed bid for AstraZeneca Plc, is also treading carefully as its executives try to get a better handle on the political winds before proceeding, two of the people said, asking not to be identified discussing private information. “Tax-inversion deals is a topic that companies are quite worried about because of the political risk,” said Colin Mayer, a professor of management studies at Said Business School at Oxford. “The issue is now much more politically sensitive, especially after Pfizer’s attempt to buy AstraZeneca.”

’Corporate Deserters’

Pfizer, one of the the biggest American drugmakers, in April tried to move its domicile to the U.K. by buying AstraZeneca. It only ended that effort after the London-based company’s board refused to enter talks and the U.K. government opposed it. Between mid-June and late-July, when Obama ramped up his criticism of the deals, at least five large American companies announced plans for inversions, including AbbVie Inc. and Medtronic Inc. Since the start of 2012, 21 U.S. companies have announced or completed such deals, or almost half the total of 51 such transactions in the last three decades. After Obama called for “economic patriotism” from business leaders in July, Treasury Secretary Jack Lew said the agency was examining options for new rules that wouldn’t require Congressional sign-off.

Future Risks

Wary of the risks of U.S. action, some companies are leaving an escape hatch open. Medtronic’s agreement to buy Irish-domiciled Covidien Plc for more than $40 billion can be called off if a law is implemented that would mean the new company could “be treated as a United States domestic corporation” for tax purposes. The increase in criticism from Washington could have an impact on pending deals such as the sale of Nobel Biocare Holding AG. The Swiss maker of dental implants has attracted interest from potential buyers including U.S.-based Danaher Corp. Earlier this year, Monsanto Co., the world’s largest seed company, explored a takeover of rival Syngenta AG that ended without an agreement. Still, few companies are going to choose acquisition targets based solely on tax advantages. There has to be a strategic logic to a deal too, said Ferdinand Mason, a corporate partner in London at law firm Jones Day. “This type of transaction helps price a deal higher due to tax savings, but that’s not the main reason why you pursue such a deal,” Mason said. “Successful deals will always be driven by strategy and strategy alone.”

Treasury’s Options

In the case of Deerfield, Illinois-based Walgreen, gaining a non-U.S. domicile would have required a change to the terms of its 2012 agreement to buy Boots, according to Michael Polzin, a spokesman for Walgreen. Those changes would have to be “commercially driven,” not tax-driven, he said. The Treasury, which answers directly to Obama as an executive branch agency, has a few options for how to make transactions harder. It could try to limit companies’ access to foreign cash to finance overseas acquisitions, and make it harder for them to use accounting moves to reduce taxable U.S. income after a deal closes. “They may be even more aggressive than usual with their regulatory authority because of a perceived need to freeze the market,” said Phil West, a former Treasury lawyer who heads the tax practice at Steptoe & Johnson LLP in Washington. The agency may try to keep its cards hidden by issuing rolling sets of guidance, so that it retains a level of strategic advantage over private-sector tax lawyers who will immediately look for ways to get around its proposals, he added. “They might like the current uncertainty just fine,” West said.

Government Ties

A company’s decision to pursue a deal in the face of political criticism will depend on what business it’s in, said Jonathan Rubin, a partner at Westbury Group LLC, an investment bank in Westport, Connecticut. “Companies that do not have significant business with, or regulatory oversight by, the federal government will face the greatest pressure to pursue them,” Rubin said. Corporations with governmental ties will “have to take the political risk into consideration. The Walgreen uproar highlighted those risks.” Two parallel trends are helping drive the popularity of inversions. European countries, eager to make their economies more competitive, are slashing corporate tax rates, while U.S. companies, with hoards of cash overseas, are seeking those lower tax rates. In the U.S. the rate is 35 percent, though most companies take advantage of various deductions to pay a lower amount.

Cash Stockpiles

Since the global financial crisis, large U.S. companies with growing international operations have built up huge cash balances they hold in offshore accounts, since bringing the money back to the U.S. would mean paying tax on it. The U.S. is one of a handful of countries that tax all of companies’ -- and individuals’ -- worldwide income. Medtronic has nearly $14 billion offshore, while Pfizer has more than $30 billion in offshore cash and investments. Moving to an overseas legal address means that money can be used for dividend payments or share buybacks with a smaller tax penalty. “Taking advantage of a tax inversion merger to reduce a company’s corporate tax rate puts more profit into the pockets of shareholders,” said Rubin. “Companies which resist that opportunity run the risk that investors will punish its stock price.”

For Related News and Information: Obama Says Tax Law Must Change to Stop ‘Corporate Deserters’ NSN N98L7R6JIJV9 <GO> Offshore Cash of $2 Trillion Sparks Hunt for Tax-Friendly Deals NSN N7A6BS6S972E <GO> Cash No Longer King as Buyers Use Stock to Fund Takeovers NSN N80Y6K6VDKHS <GO> Top Stories: TOP <GO> Top Deal News: DTOP <GO> --With assistance from Richard Rubin in Washington and Zachary R. Mider in New York.

To contact the reporters on this story: Matthew Campbell in London at +44-20-3525-8684 or mcampbell39@bloomberg.net; Manuel Baigorri in London at +44-20-3525-4457 or mbaigorri@bloomberg.net; David Welch in New York at +1-212-617-2788 or dwelch12@bloomberg.net To contact the editors responsible for this story: Mohammed Hadi at +1-212-617-2914 or mhadi1@bloomberg.net; Aaron Kirchfeld at +44-20-3525-8830 or akirchfeld@bloomberg.net Larry Reibstein, Whitney Kisling

FT : Market watchdog issues cyber attack warning

Market watchdog issues cyber attack warning

A global watchdog has sounded the alarm about the growing danger of cyber attacks, on financial markets, warning that firms and regulators around the world need to address the "uneven" response to the threat of online assaults. Greg Medcraft, chairman of the board of the International Organisation of Securities Commissions (Iosco), predicted that the next major financial shock – or "black swan event" – will come from cyber space, following a succession of attacks on financial players. He warned that there needed to be a more concerted effort to tackle cyber threats around the world as current approaches varied widely. "The feedback we have had from industry in discussions is that there is not a consistency in approach," he said. Recent big hacking attacks against US retailer Target, which had the credit card data of up to 40m shoppers stolen, and eBay – as well as the "Heartbleed" bug discovered in software used to secure two-thirds of the web – have exposed the vulnerability of websites to attack. Regulators are looking at producing a global "toolbox" next year to assess whether firms are sufficiently robust and managing their risks adequately. The idea is to identify risk management standards for detecting and responding to cyber-incursions, Mr Medcraft said, building on work pioneered in the US. "The issue of cyber resilience is a bit of a sleeper issue, and one that we have to be proactive [about] in terms of making sure the risk management approach is robust," Mr Medcraft said in an interview with the Financial Times. "Cyber crime has a huge potential impact on markets." The US Securities and Exchange Commission in April said it would examine the cyber resilience of more than 50 broker-dealers and investment advisers. SEC chairman Mary Jo White has said cyber threats were of "extraordinary and long-term seriousness" and called for the public and private sectors to be "riveted, in lockstep, in addressing these threats". Mr Medcraft, who is also chairman of the Australian Securities & Investments Commission, said: "The starting point is to look at what the Americans have done . . . and look at those risk-management principles and see how they could translate globally." The focus is on firms including broker dealers, fund managers, companies listed on stock markets and the stock markets themselves. He added: "The next black swan event will come from cyber space. It is important that we pay attention." Richard Horne, cyber security partner at PwC, the accountants, said: "Financial markets are globally interconnected and dependent and the financial system is only as strong as its weakest link. "As things stand the regulatory approach around the world is very patchy, so we need more co-ordination and consistency. Iosco’s move on this is a welcome step forward." Iosco, an umbrella body whose members include more than 120 securities regulators, has been highlighting cyber risks after last year releasing a report showing that more than half of securities exchanges had been on the receiving end of an attack. Some 89 per cent of the exchanges it surveyed said they viewed cyber crime as a potential systemic risk, citing the danger of major financial or reputational damage and the threat of a catastrophic loss of confidence. Forty-six securities exchanges responded to the survey, which was conducted with the World Federation of Exchanges. Concern about a possible state-sponsored attack on financial systems has been heightened after last year’s hacking of computer systems at South Korean banks and broadcasters, which originated from a Chinese internet address and was blamed by Seoul on North Korea. In Britain, the Bank of England has been overseeing a programme of "ethical hacking" aimed at assessing the ability of leading players including banks and insurers to fend off cyber assaults. That follows the country’s so-called Waking Shark II process, when City institutions conducted a simulated war game to check where vulnerabilities lay.

Roche Said to Have Decided Against Bid for Rest of Chugai

+------------------------------------------------------------------------------+

BN 08/24 19:02 *ROCHE SAID TO STRIKE INTERMUNE DEAL INSTEAD OF BID FOR CHUGAI BN 08/24 19:02 *ROCHE SAID TO HAVE CONSIDERED BIDDING FOR ALMOST 40% OF CHUGAI BN 08/24 19:02 *CHUGAI MGMT SAID TO HAVE SIGNALED OPPOSITION TO ROCHE BID BFW 08/24 19:02 *ROCHE SAID TO HAVE DECIDED AGAINST BID FOR REST OF CHUGAI

+------------------------------------------------------------------------------+

Roche Said to Have Decided Against Bid for Rest of Chugai 2014-08-24 19:08:10.286 GMT

By Brad Skillman Aug. 24 (Bloomberg) -- Chugai said to have signaled opposition to Roche bid * Roche said to have considered bidding for almost 40% of Chugai stake it didn’t own, struck Intermune deal instead * NOTE: Roche to Buy Intermune for $74/Shr, 63% Premium From 8/12 {NSN NATMZE6KLVR5<Go>} * Related story: {NSN NATS8X6K50XT<Go>}

Link to Company News:{4519 JP <Equity> CN <GO>} Link to Company News:{ITMN US <Equity> CN <GO>} Link to Company News:{ROG VX <Equity> CN <GO>}

For Related News and Information: First Word scrolling panel: {FIRST<GO>} First Word newswire: {NH BFW<GO>}

To contact the editor responsible for this story: Brad Skillman at +1-212-617-2763 or bskillman1@bloomberg.net